SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced that it is formalizing its decades-long approach to improving scientific and business outcomes for laboratories by delivering insights based on the team’s industry-leading knowledge and backed by Agilent’s broad and expanding solutions portfolio. Through the company’s Agilent CrossLab program, its products, services and employees […]
CARLSBAD, Calif. — Clinical researchers from the Saudi Human Genome Program (SHGP), a national research project focused on studying the genetic basis of all disease in the Kingdom and throughout the Middle East, presented data that demonstrates groundbreaking results suggesting the potential to one day diagnose inherited diseases through genetic tests based on a collection […]
WILMINGTON, Mass. — Kapa Biosystems, Inc., today launched a new RNA library preparation product for next-generation sequencing (NGS) workflows that enables users to generate a more complete view of the transcriptome by detecting more low-abundance and unique transcripts. The KAPA Stranded RNA-Seq Kit with RiboErase uses a targeted enzymatic depletion method to remove ribosomal RNA […]
SANTA CLARA, Calif. — Affymetrix, Inc., (NASDAQ:AFFX) announced today that it has acquired substantially all the assets of Hercules, CA-based Eureka Genomics® Corporation for $15 million in an all cash transaction. Eureka Genomics is a developer of cost-effective, low- to mid-plex, high throughput genotyping assays that use common next-generation sequencing (NGS) platforms for signal readout. […]
LEXINGTON, Mass. -– N-of-One, Inc. , the leading provider of clinical interpretation evidence, today announced that CellNetix Pathology and Laboratories has adopted N-of-One’s new clinical trial matching solution, TrialMatch™, as well as N-of-One clinical interpretation evidence services. Under this agreement, N-of-One will provide industry-leading clinical interpretation evidence as well as molecular profile-based clinical trial matching […]
THOUSAND OAKS, Calif. — Ceres, Inc. (NASDAQ: CERE), an agricultural biotechnology company, today announced that the company has licensed its Persephone bioinformatics software to global seed potato developer, HZPC Holland BV. The software license agreement provides a non-exclusive license to HZPC as well as professional support services. HZPC is the most recent multi-national life sciences […]
SEATTLE, WA – Adaptive Biotechnologies, a leader and pioneer in next generation sequencing (NGS) of T-cell and B-cell receptors in the immune system, announced today the completion of Adaptive’s Series F financing round with a $195 million investment to support several strategic growth initiatives. This round was led by Matrix Capital Management and included other […]
TUCSON, Ariz.– HTG Molecular Diagnostics, Inc., a provider of instruments and reagents for molecular profiling applications, today announced the pricing of its initial public offering of 3,570,000 shares of its common stock at an initial public offering price of $14.00 per share. All of the shares of common stock are being offered by HTG. The […]
MENLO PARK, Calif. and BILLERICA, Mass. — Pacific Biosciences of California, Inc. (Nasdaq:PACB), provider of the PacBio® RS II Sequencing System, and RainDance Technologies, Inc., a genomics tools company dedicated to simplifying the analysis of complex genetic diseases, today announced their entry into a co-development and co-marketing agreement to commercialize novel solutions for de novo […]
NEW YORK CITY — IBM Watson Health (NYSE: IBfM) today announced that it is collaborating with more than a dozen leading cancer institutes to accelerate the ability of clinicians to identify and personalize treatment options for their patients. The institutes will apply Watson’s advanced cognitive capabilities to reduce from weeks to minutes the ability to […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
